HUNTINGDON VALLEY, Pa.–Immunicon Corporation (NASDAQ:IMMC – News) announced today that it is exploring and evaluating various financial and strategic alternatives for the Company, including the sale of some or all of its businesses. Immunicon has retained Stifel, Nicolaus & Company as its financial advisor to assist in exploring and evaluating various financial and strategic alternatives […]
Ann Arbor, MI – April 7, 2008. Accuri Cytometers, Inc. today announced the commercial launch of the Accuri C6 Flow Cytometer™ System, designed to bring the power of flow cytometry cell analysis to the laboratory of every life sciences researcher. The Accuri C6 is a bench-top system that delivers performance and features similar to those […]
TORONTO–Axela Inc., a recognized innovator in protein interaction technology, announced today it has expanded its Board of Directors as the company positions itself for growth in the diagnostic, life science, and pharmaceutical research markets. Joining Axela’s board are Dave Lemus, David Giddings, and Bill Clarke, MD. The new board members have a strong background in […]
Allows researchers to assess small samples in high throughput qPCR PENZBERG, Germany & SAN CARLOS, Calif.–Roche Applied Science and NuGEN Technologies, Inc., a privately held company that develops and commercializes highly sensitive nucleic acid amplification and labeling systems, announced today an agreement that will enable Roche to market and sell an RNA amplification product based […]
MADISON, Wis.–Promega Corporation announces the launch of a breakthrough cell-based biosensor technology, termed GloSensor™ Technology. The non-lytic, live-cell GloSensor cAMP Assay is the first application of the patent-pending technology, which features a genetically engineered form of firefly luciferase. The benefit to screeners and scientists alike will be more biologically relevant data captured directly from living […]
Joseph H. Griffith IV Promoted to Vice President of Finance HOPKINTON, Mass., April 3, 2008 — Caliper Life Sciences, Inc. (Nasdaq: CALP – News) today announced the promotion of Peter F. McAree to Senior Vice President and Chief Financial Officer. McAree previously served as Vice President of Finance at Caliper. Effective April 4, Thomas Higgins […]
Tripos receives U.S. Patent protection and approval for innovative Topomer technologies; Topomer tools now linked for even more powerful compound searches ST. LOUIS–Tripos International, leading provider of drug discovery informatics products and services, today announced the availability of integrated versions of its recently patented Topomer Search and Topomer CoMFA® technologies. Tripos’ Topomer technologies accelerate the […]
SAN DIEGO–Sequenom, Inc. (NASDAQ:SQNM – News), a leading provider of genetic analysis solutions, today updated its 2008 financial guidance. Revenues for the first quarter of 2008 will exceed revenues for the first quarter of 2007; however, while sales of MassARRAY® systems in Europe and the rest of the world were in line with expectations, sales […]
NEW YORK–Cell Kinetics Ltd. (OTCBB: CKNTF – News), announced today that it has signed with Rikaken Co., Ltd. an exclusive distribution agreement for the marketing and distribution of Cell Kinetics’ “CKChip™” in Japan. “This is a significant moment for Cell Kinetics. This distribution agreement with Rikaken reflects the first step in our commercialization plans to […]
SAN DIEGO–Nanogen, Inc. (Nasdaq:NGEN – News), developer of molecular-biology and rapid diagnostic products, and Thermo Fisher Scientific Inc., the world leader in serving science, have entered into an agreement in which Thermo Fisher will be the exclusive provider of a variety of products used in gene-expression experiments. These products are based on Nanogen’s second generation […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
